Definitive Contract 75N93022C00011

Award Date 7/1/22

Potential Completion Date 12/31/23

Potential Value $300K

Federal Agency

National Institute of Allergy and Infectious Diseases

Awardee

Antagen Biosciences Inc.

Ultimate Awardee

Not listed

NAICS Category

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

PSC Category

AN12 - Health R&D Services; Health Care Services; Applied Research

Federal Contract Vehicle

Set-Aside Type

Total Small Business

Extent Competed

Full and Open Competition after exclusion of sources

Major Defense Program

Not listed

Pricing Type

Firm Fixed Price

Place of Performance

Canton, MA 02021, USA

Solicitation Procedures

Negotiated Proposal / Quote

Number Of Offers Received

Legislative Mandate

Employment Eligibility Verification

National Interest Action

Not listed

Research Type

SBIR Program Phase I Action

Primary Consortia Member

Not listed

Antagen Biosciences Inc., doing business as Antagen Pharmaceuticals, has been awarded a $299,998 firm fixed price Small Business Innovation Research (SBIR) contract from the National Institutes of Health's National Institute of Allergy and Infectious Diseases. Under this contract, Antagen will further develop its novel protein nanoparticle-based expression and delivery system using FcRider technology and antibody afucosylation technology to produce an engineered HIV envelope glycoprotein intended to induce broadly neutralizing antibodies against HIV. This award is set aside for total small business participation and supports the SBIR program's goals of stimulating technological innovation and strengthening the role of small businesses in meeting federal research and development needs.

Generated 2/8/24, 10:08 AM

Name	Solicitation Number	Federal Agency	Type	Posted Date (Click to sort descending)
A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals	PHS-2022-1	Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases	Pre-Solicitation 1/8	7/12/21, 7:20 PM
A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals	PHS-2022-1	Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases	Solicitation 2/8	7/30/21, 8:40 AM
Preclinical Evaluation of HIV-1 Envelope Immunogens in Humanized Mice	75N93022C00029	Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases	Award Notice 4/8	7/6/22, 9:44 AM
FcRider-based Expression and Delivery of Stable Env Immunogens for HIV Vaccines	75N93022C00011	Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases	Award Notice 3/8	7/1/22, 9:18 AM
The IRIS-HIV Assay, a Point-of-Care, Multiplex Serological Assay to Identify HIV Infection and Vaccine-Induced Seropositivity	75N93022C00030	Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases	Award Notice 5/8	7/6/22, 12:50 PM

Mod #	Description	Reason For Modification	Federal Obligation (Click to sort descending)	Date (Click to sort ascending)
P00001		Other Administrative Action	$0	5/24/23
Not listed		Not listed	$300.0k	6/24/22

Plans
Login

Blog